Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.

Kane JM, Lauriello J, Laska E, Di Marino M, Wolfgang CD.

J Clin Psychopharmacol. 2008 Apr;28(2 Suppl 1):S29-35. doi: 10.1097/JCP.0b013e318169cca7.

PMID:
18334910
2.

Iloperidone for the treatment of schizophrenia.

Marino J, Caballero J.

Ann Pharmacother. 2010 May;44(5):863-70. doi: 10.1345/aph.1M603. Epub 2010 Apr 13. Review.

PMID:
20388862
3.

Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2009 Aug;63(8):1237-48. doi: 10.1111/j.1742-1241.2009.02142.x. Review.

PMID:
19624791
4.

Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.

Fowler JA, Bettinger TL, Argo TR.

Clin Ther. 2008 Feb;30(2):231-48. doi: 10.1016/j.clinthera.2008.02.011. Review.

PMID:
18343262
5.

An assessment of iloperidone for the treatment of schizophrenia.

Jain KK.

Expert Opin Investig Drugs. 2000 Dec;9(12):2935-43. Review.

PMID:
11093363
6.

Iloperidone: a new option for the treatment of schizophrenia.

Cutler AJ.

Expert Rev Neurother. 2009 Dec;9(12):1727-41. doi: 10.1002/pmic.200800563. Review.

PMID:
19951132
7.

New atypical antipsychotics for schizophrenia: iloperidone.

Caccia S, Pasina L, Nobili A.

Drug Des Devel Ther. 2010 Feb 18;4:33-48. Review.

8.

Antipsychotic medication in the treatment of schizophrenia.

Kane JM.

Isr J Psychiatry Relat Sci. 1995;32(1):30-7. Review.

PMID:
7542642
9.

Iloperidone: A new drug for the treatment of schizophrenia.

Arif SA, Mitchell MM.

Am J Health Syst Pharm. 2011 Feb 15;68(4):301-8. doi: 10.2146/ajhp100079. Review.

PMID:
21289324
10.

Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.

De Hert M, Yu W, Detraux J, Sweers K, van Winkel R, Correll CU.

CNS Drugs. 2012 Sep 1;26(9):733-59. doi: 10.2165/11634500-000000000-00000. Review.

PMID:
22900950
11.

Safety profile of iloperidone in the treatment of schizophrenia.

Dargani NV, Malhotra AK.

Expert Opin Drug Saf. 2014 Feb;13(2):241-6. doi: 10.1517/14740338.2014.854770. Epub 2013 Nov 11. Review.

PMID:
24206391
12.

Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2011 Feb;65(2):189-210. doi: 10.1111/j.1742-1241.2010.02587.x. Epub 2010 Dec 3. Review.

PMID:
21129135
13.

Iloperidone for the management of adults with schizophrenia.

Crabtree BL, Montgomery J.

Clin Ther. 2011 Mar;33(3):330-45. doi: 10.1016/j.clinthera.2011.03.006. Review.

PMID:
21600386
14.

Iloperidone: in schizophrenia.

Scott LJ.

CNS Drugs. 2009 Oct;23(10):867-80. doi: 10.2165/10489070-000000000-00000. Review.

PMID:
19739696
15.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
16.

Iloperidone: a clinical overview.

Citrome L.

J Clin Psychiatry. 2011;72 Suppl 1:19-23. doi: 10.4088/JCP.10075su1.04. Review.

17.

Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?

Albers LJ, Musenga A, Raggi MA.

Expert Opin Investig Drugs. 2008 Jan;17(1):61-75. Review.

PMID:
18095919
18.

Safety profile of amisulpride in short- and long-term use.

Rein W, Coulouvrat C, Dondey-Nouvel L.

Acta Psychiatr Scand Suppl. 2000;400:23-7. Review.

PMID:
10823308
19.

Iloperidone for the treatment of schizophrenia: an updated clinical review.

Weiden PJ.

Clin Schizophr Relat Psychoses. 2012 Apr;6(1):34-44. doi: 10.3371/CSRP.6.1.5. Review.

PMID:
22453868
20.

Paliperidone extended-release for the treatment of schizophrenia.

Marino J, Caballero J.

Pharmacotherapy. 2008 Oct;28(10):1283-98. doi: 10.1592/phco.28.10.1283. Review.

PMID:
18823223

Supplemental Content

Support Center